Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST001795)

(Analysis AN002915)

Metabolite	Structure	F1	F2	F3
Altretamine	ME416513	1.83	0.78	0.37
Burseran	ME416516	1.79	0.88	0.33
Cer 35:0;O2	ME416533	1.23	1.25	0.52
Cer 33:0;O2	ME416531	1.53	0.95	0.52
3-Dimethylallyl-4-hydroxymandelic acid	ME416482	1.34	0.91	0.75
CAR 16:1;OH	ME416520	1.41	0.89	0.68
Dihydroceramide	ME416486	1.23	1.02	0.75
CAR 14:1	ME416518	1.11	1.12	0.78
Margaroyl-EA	ME416569	1.11	1.16	0.75
LPC 16:1(9Z)*	ME416550	0.97	0.97	1.06
PA O-32:0	ME416588	0.95	0.96	1.07
8-hydroxy-13Z-octadecene-9_11-diynoic acid	ME416467	1.03	0.90	1.05
PA P-32:1 or PA O-32:2	ME416593	1.03	0.95	1.01
PA P-34:2 or PA O-34:3	ME416596	1.03	0.95	1.02
Cer 41:1;O2	ME416537	1.00	0.95	1.04
N-(2-hydroxy-docosanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine	ME416472	1.02	0.94	1.04
Cer 41:0;O2	ME416536	0.95	1.05	1.01
Estradiol-17-phenylpropionate	ME416481	0.99	1.08	0.94
LPC 20:1	ME416554	0.98	1.11	0.92
[FA hydroxy(20:4)] eicosatetraenoyl amine	ME416480	0.97	1.07	0.97
LPC 16:0	ME416549	1.00	1.04	0.97
4-8dimethylnonanoylcarnitine	ME416479	1.00	1.05	0.96
Linoleamide	ME416546	1.00	1.05	0.96
N-(2-hydroxyoctadecanoyl)-phytosphingosine	ME416465	1.08	0.98	0.94
PA 44:6	ME416585	1.07	1.00	0.93
2-Aminotetradecanoic acid	ME416508	1.10	1.07	0.84
LPE 16:0	ME416563	1.04	1.08	0.89
PA 42:10	ME416583	1.07	1.04	0.90
MG 14:0	ME416570	1.25	0.75	0.97
(1R_4S)-fenchan-2-one	ME416478	1.14	0.96	0.90
N-(2-hydroxyicosanoyl)-phytosphingosine	ME416455	1.15	0.91	0.89
4_8-Dimethyl-1_3E_7-nonatriene	ME416477	1.16	0.94	0.89
FA (14:2) tetradecadienal	ME416475	1.17	0.92	0.90
PA O-34:0	ME416589	1.09	0.88	0.98
[FA (18:2)] 3Z_13Z-octadecadien-1-ol	ME416468	1.17	0.84	0.97
Hexadecenal	ME416471	1.19	0.85	0.94
14:4(2E_4E_8E_10E)(6Me[S]_9Me_12Me[S])	ME416492	0.91	1.35	0.74
14^-apo-beta-Carotenal	ME416507	0.92	1.35	0.76
3_5_7-Trimethyl-2E_4E_6E_8E-decatetraene	ME416493	0.91	1.44	0.69
Eicosanoyl-EA	ME416542	0.92	1.41	0.71
LPE 20:2	ME416565	0.80	1.49	0.77
4-Dodecylphenol	ME416511	0.85	1.48	0.73
CAR 14:0	ME416517	0.83	1.47	0.75
5beta-cholestan-3alpha_4alpha_11beta_12beta_21-pentol-3_21-disulphate	ME416490	0.82	1.43	0.82
LPC 20:0	ME416553	0.86	1.39	0.79
beta-Estradiol	ME416515	1.03	1.32	0.69
FA oxo(19:0)	ME416494	1.03	1.42	0.60
Falcarindiol	ME416488	1.00	1.19	0.83
LPC 20:2	ME416555	0.93	1.14	0.94
Cholestenone	ME416538	0.94	1.18	0.90
LPC P-18:1 or LPC O-18:2	ME416562	0.95	1.19	0.89
10_11-Dihydro-12R-hydroxy-leukotriene E4	ME416447	0.93	1.37	0.95
LPC 22:5	ME416559	0.87	1.22	0.93
Magnoshinin	ME416568	0.81	1.25	0.98
Arachidonoyl-EA	ME416514	0.81	1.32	0.90
all-trans-13_14-Dihydroretinol	ME416489	0.92	1.25	0.86
LPC 18:1	ME416552	0.88	1.29	0.86
Cer 33:1;O2	ME416532	0.86	1.14	1.02
DG 42:9	ME416540	0.81	1.03	1.13
3Z_6Z_9Z-Tricosatriene	ME416476	0.83	0.84	1.50
Cer 18:1;O2/24:1	ME416530	1.15	0.80	1.02
3_5_7-Trimethyl-2E_4E_6E_8E-undecatetraene	ME416463	1.11	0.80	1.06
LPC 24:1(15Z)*	ME416561	1.10	0.80	1.08
haematoporphyrin IX	ME416462	1.04	0.81	1.14
N-Acetyl-beta-glucosaminylamine	ME416571	1.05	0.82	1.11
PA O-30:0	ME416587	1.03	0.80	1.11
9_12-Hexadecadienoylcarnitine	ME416461	1.11	0.76	1.10
acyl phosphatidylglycerol (n-C12:0)	ME416460	1.13	0.74	1.11
LPC 22:0	ME416558	1.09	0.73	1.15
LPC 18:0	ME416551	1.10	0.75	1.12
Oleamide	ME416572	1.10	0.74	1.13
LPC 20:3	ME416556	1.08	0.76	1.13
LPC 20:4	ME416557	1.09	0.77	1.12
Glucosylceramide (d18:1/24:1(15Z))	ME416456	1.06	0.70	1.21
Himbacine	ME416458	1.06	0.74	1.17
1-eicosanoyl-(1-cyano-2-methylprop-2-en-1-ol)	ME416453	0.98	0.70	1.28
N-(5-hydroxy-pentyl)-5Z_8Z_11Z_14Z-eicosatetraenoyl amine	ME416457	0.92	0.77	1.29
Hymenoflorin	ME416545	0.91	0.91	1.27
N_N-Dimethylsphing-4-enine	ME416464	0.95	0.89	1.14
(9S_10S)-10-Hydroxy-9-(phosphonooxy)octadecanoate	ME416451	0.93	0.79	1.19
alpha-Linolenoyl-EA	ME416512	0.96	0.82	1.20
Cer 36:1;O2	ME416534	1.14	0.46	0.98
N-(2-hydroxyeicosanoyl)-sphinganine	ME416430	1.07	0.37	1.16
PA 40:3	ME416581	1.19	0.41	1.13
Cer 18:0;O2/16:0	ME416522	1.28	0.55	1.11
[FA (16:2)] N-hexadecyl-ethanolamine	ME416452	1.24	0.58	1.13
LPC 14:0	ME416548	1.26	0.59	1.11
PA P-30:1 or PA O-30:2	ME416592	1.17	0.63	1.04
3-beta-Hydroxy-4-beta-methyl-5-alpha-cholest-7-ene-4-alpha-carboxylate	ME416509	1.22	0.67	1.06
Cer 18:1;O2/16:0	ME416528	1.24	0.63	1.09
Cer 18:0;O2/24:0;O	ME416525	1.17	0.60	1.18
N-(2-hydroxydocosanoyl)-sphinganine	ME416440	1.23	0.46	1.25
1-(14-methyl-pentadecanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerol	ME416441	1.17	0.51	1.26
FA oxo(21:0)	ME416439	1.16	0.51	1.22
CAR 16:0	ME416519	1.20	0.51	1.23
Cer 18:1;O2/24:0	ME416529	1.18	0.53	1.23
Cer 40:1;O2	ME416535	1.23	0.50	1.21
N-(2-hydroxynonadecanoyl)-phytosphingosine	ME416443	1.23	0.53	1.18
Cer 18:0;O2/24:0	ME416524	1.14	0.47	1.33
GlcCer 14:1;O2(4E)/20:0;O	ME416544	1.09	0.53	1.33
Glucosylceramide	ME416437	1.03	0.53	1.28
LPC 24:0	ME416560	1.11	0.62	1.22
anhydroretinol	ME416442	1.06	0.60	1.26
Glucosylceramide (d18:1/16:0)	ME416444	1.09	0.58	1.29
Glucosylceramide (d18:1/22:0)	ME416445	1.12	0.57	1.26
1-O-Octadec-9-enyl glycerol	ME416429	0.90	0.19	1.96
Minabeolide-2	ME416423	0.88	NA	1.08
MG(0:0/22:2(13Z_16Z)/0:0)	ME416425	1.10	NA	0.90
PA 22:0/0:0*	ME416574	1.10	NA	0.90
PA 34:0	ME416577	1.08	NA	0.92
PA 17:0/14:1*	ME416573	1.07	NA	0.93
LPC 12:0	ME416547	1.06	NA	0.94
N-(2-hydroxyundecanoyl)-phytosphingosine	ME416424	1.06	NA	0.94
PA P-28:0 or PA O-28:1	ME416590	1.07	0.02	1.04
Erucicoyl-EA	ME416543	1.03	NA	0.98
N-(2-hydroxyoctadecanoyl)-sphinganine	ME416426	1.02	NA	0.98
PA 38:0	ME416579	1.02	NA	0.98
PA 40:1	ME416580	0.99	NA	1.01
PA 44:1	ME416584	0.95	NA	1.05
PA 36:0	ME416578	0.96	NA	1.04
PA 42:1	ME416582	0.97	NA	1.03
Cer 18:0;O3/13:0;O	ME416526	1.35	0.06	1.06
Cer 18:0;O3/15:0;O	ME416527	1.37	0.15	1.20
1-Dodecanoyl-sn-glycerol	ME416428	1.48	0.13	1.29
FA oxo(15:0)	ME416431	1.42	0.21	1.28
Octadecadienal	ME416435	1.38	0.32	1.22
CAR 18:1	ME416521	1.28	0.37	1.28
PA P-34:1 or PA O-34:2	ME416595	1.31	0.31	1.30
PA O-28:0	ME416586	1.21	0.25	1.12
PA P-30:0 or PA O-30:1	ME416591	1.25	0.19	1.20
PA P-34:0 or PA O-34:1	ME416594	1.25	0.17	1.30
di-n-Undecylamine	ME416427	1.06	0.04	1.43
CTAB	ME416433	1.05	0.36	1.52
FA oxo(14:1) cyclopentanebutanoic acid	ME416434	0.98	0.40	1.55
Cer 18:0;O2/22:0	ME416523	1.21	0.35	1.37
Docosanamide	ME416541	1.14	0.33	1.46
16alpha-Hydroxysteroid	ME416504	0.19	2.89	0.13
N-(11Z_14Z-eicosadienoyl)-ethanolamine	ME416501	0.57	2.15	0.40
[FA methyl(18:0)] 9_10-methylene-9-octadecenoic acid	ME416503	0.43	2.42	0.31
[FA (17:3)] 8Z_11Z_14Z-heptadecatrienoic acid	ME416502	0.40	2.37	0.38
LPE 22:0	ME416566	0.40	2.31	0.43
7_10_13_16-Docosatetraenoylethanolamine	ME416496	0.86	1.62	0.58
PA 30:3	ME416576	0.64	1.63	0.59
[FA (17:1)] 7-heptadecynoic acid	ME416495	0.66	1.76	0.67
LPE 20:0	ME416564	0.65	1.78	0.66
Coniferyl alcohol	ME416539	0.68	1.70	0.70
3-Ketosphingosine	ME416510	0.70	1.67	0.70
LPE 22:1	ME416567	0.73	1.66	0.69
Antibiotic TA	ME416500	0.37	1.93	0.57
Noladin Ether	ME416497	0.59	1.94	0.53
PA 26:0	ME416575	0.60	1.89	0.61

Factors:

F1	Treatment:Celecoxib_HFD
F2	Treatment:CFD
F3	Treatment:HFD

Data matrix